Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Start-Up Quarterly Statistics: Financings Finally Rise In Q1, But Deals Stagnate

May 08 2018

• By Deanna Kamienski

Start-Up Quarterly Statistics regular column feature image

Related Content

With Back-To-Back FDA Holds, Solid Hopes To Regain Footing For Duchenne Candidate

Apr 18 2018

Keeping Track: US FDA Refuses To File Acorda, SteadyMed NDAs

Sep 04 2017

Deal Watch: Roche Goes All-In On Real-World Data With Flatiron Acquisition

Feb 19 2018

Poxel's Phase III Oral Diabetes Therapy Taken Up By Roivant

Feb 12 2018

Takeda Catches Rising Tide Of Antisense Neuroscience R&D

Feb 21 2018

TCR2 Raises $125m To Make T-Cell Therapies Available To More Cancer Patients

Mar 21 2018

Deal Watch: Ionis Turns To Affiliate Akcea In Amyloidosis

Mar 15 2018

Deal Watch: Opportunity Knocks For Partnerships In Asia

Mar 27 2018

IPO Update: Will Declining Returns Slow Fast Pace Of Biopharma Offerings?

Apr 03 2018

Venture Funding Deals: Celularity Launches With $250m; Generation Bio Grabs $100m Series B

Mar 06 2018

Deal Watch: Roivant Adds Ligand's Glucose Receptor Antagonist To Metavant Pipeline

Mar 07 2018

Cardiome to sell SteadyMed drug

Jun 29 2015

J.P. Morgan Notebook Day 4: CRISPR's Not Worried; Theratechnologies' HIV Niche; And Is Moderna's IPO Coming Soon?

Jan 12 2018

Celgene's $1.1bn Impact Buy Is First Of More Deals To Come In 2018 And Beyond

Jan 09 2018

Deal Watch: As J.P. Morgan Waits For New Deals, Sanofi Takes Care Of Old Business

Jan 10 2018

AstraZeneca Keeps R&D Focus, Spins Out Phase II Neuromyelitis Optica MAb Into New Biotech

Feb 28 2018

What Was On Hold Is New Again As Impact Raises $22.5m For Fedratinib

Oct 13 2017

Rubius Prepares Off-The-Shelf Red Cell Therapies For First Human Trial In 2018

Oct 12 2017

Related Companies

Viela Bio, Inc.

Celularity, Inc.

MedImmune LLC

Bristol Myers Squibb Company

United Therapeutics Corporation

Sorrento Therapeutics, Inc.

Human Longevity, Inc.

TCR² Therapeutics Inc.

Rubius Therapeutics, Inc.

Homology Medicines, Inc.

Solid Biosciences Inc.

Arcus Biosciences, Inc.

CRISPR Therapeutics AG

Takeda Pharmaceutical Co. Ltd.

Wave Life Sciences Ltd.

Denali Therapeutics Inc.

Ionis Pharmaceuticals, Inc.

Akcea Therapeutics, Inc.

Roivant Sciences Ltd.

Roivant Sciences Ltd.

ArQule, Inc.

Poxel SA

Sumitomo Pharma Co., Ltd.

Roivant Sciences Ltd.

Ligand Pharmaceuticals, Inc.

Impact Biomedicines, Inc.

Incyte Corporation

Sanofi

Cipher Pharmaceuticals Inc.

Cardiome Pharma Corp.

Additional Topics

Deals Financing StartUps and SMEs Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window